29 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Mar 2037. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Mar 2037
Next term end
15
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends no later than May 2037 · Low confidence
Also notable
Ends May 2037 · Medium confidence
Also notable
Ends Nov 2039 · High confidence
Droplet Delivery Device for Delivery of Fluids to the Pulmonary System and Methods of Use
US 9,962,507
The most cited patent in this portfolio, cited by 70 later US patents, top 5% of utility patents granted in 2018 in our data. Protection runs to 2037. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Methods for Generating and Delivering Droplets to the Pulmonary System Using a Droplet Delivery Device
US 11,285,283
Cited by 22 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2037. A terminal disclaimer caps this term to an earlier patent's.
Nasal Drug Delivery Apparatus and Methods of Use
US 11,458,267
Cited by 29 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2039.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 28, 2027The maintenance fee for Electronic Breath Actuated In-Line Droplet Delivery Device and Methods of Use (US 11,738,158) comes due Feb 28, 2027. Unpaid by Aug 30, 2027, it lapses early.
- 3 fees due Apr 3 to 24, 2027 · next Apr 3
- 1 fee due Jul 7, 2027The maintenance fee for Droplet Delivery Device for Delivery of Fluids to the Pulmonary System and Methods of Use (US 10,525,220) comes due Jul 7, 2027. Unpaid by Jan 7, 2028, it lapses early.
Recent changes
- Nov 11Assignment recorded on 1 record: Hunter, Charles Eric and 10 others to Pneuma Respiratory, Inc. Recorded Nov 11, 2026, executed Jun 21, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76712, frame 488.
- 4 of the patents on this record were granted since Aug 20, 2026
What they patent
The 5 largest of its 15 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Droplet Delivery Device for Delivery of Fluids to the Pulmonary System and Methods of Use | 9 in force | to May 2037 |
| Methods for Generating and Delivering Droplets to the Pulmonary System Using a Droplet Delivery Device | 5 in force | to May 2037 |
| Droplet Delivery Device with Push Ejection | 2 in force | to Jun 2042 |
| Nasal Drug Delivery Apparatus and Methods of Use | 2 in force | to Nov 2039 |
| Ultrasonic Breath Actuated Respiratory Droplet Delivery Device and Methods of Use | 1 in force | to Jul 2043 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US D945,698 | Inhaler In force · High confidence | In force | High confidence | |
| US 9,956,360 | Methods for Generating and Delivering Droplets to the Pulmonary System Using a Droplet Delivery Device In force · Low confidence | In force | Low confidence | |
| US 9,962,507 | Droplet Delivery Device for Delivery of Fluids to the Pulmonary System and Methods of Use In force · Low confidence | In force | Low confidence | |
| US 10,449,314 | Droplet Delivery Device for Delivery of Fluids to the Pulmonary System and Methods of Use In force · Low confidence | In force | Low confidence | |
| US 10,525,220 | Droplet Delivery Device for Delivery of Fluids to the Pulmonary System and Methods of Use In force · Low confidence | In force | Low confidence | |
| US 10,898,666 | Methods for Generating and Delivering Droplets to the Pulmonary System Using a Droplet Delivery Device In force · Low confidence | In force | Low confidence | |
| US 11,285,274 | Methods for the Systemic Delivery of Therapeutic Agents to the Pulmonary System Using a Droplet Delivery Device In force · Medium confidence | In force | Medium confidence | |
| US 11,285,283 | Methods for Generating and Delivering Droplets to the Pulmonary System Using a Droplet Delivery Device In force · Medium confidence | In force | Medium confidence | |
| US 11,285,284 | Methods for Treatment of Pulmonary Lung Diseases with Improved Therapeutic Efficacy and Improved Dose Efficiency In force · Medium confidence | In force | Medium confidence | |
| US 11,285,285 | Systems and Methods Comprising a Droplet Delivery Device and a Breathing Assist Device for Therapeutic Treatment In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 29: 39 applications pending · 11 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.